ClinicalTrials.gov registry FOXO4-DRI search (no registered human trials as of June 2026)
By helping to lower inflammation, TB-4 frag may help the recovery process from chronic injuries and support those with chronic health issues
It supports circadian rhythm and stress-hormone balance and is applied for insomnia, jet lag, shift-work disruption, and high-stress lifestyles where recovery is a priority
Where It Goes The injection is subcutaneous, given in the abdomen (avoiding a 2-inch radius around the belly button), upper outer thigh, or back of the upper arm
And personal communication with author Jan 31, 2002
2 At the July meeting, an FDA advisory committee will review several high-profile research-grade peptides including BPC-157, TB-500, KPV, and MOTs-C for possible inclusion on the 503A Bulks List, which would create a pathway for compounding under medical supervision